LIFU for Chronic Pain and Generalized Anxiety Disorder
Official title: Accelerated Low-Intensity Focused Ultrasound (LIFU) for Chronic Pain and Generalized Anxiety Disorder: A Proof-of-Concept Case Series
Run by Virginia Polytechnic Institute and State University · NCT07686354 · Data updated 2026-11-12
A small, one-arm study will test whether accelerated low-intensity focused ultrasound can help people with chronic pain or generalized anxiety disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Virginia Polytechnic Institute and State University Academic / other |
| Locations | 1 site (Roanoke, Virginia) |
| Status | Recruiting |
| Started | December 2026 |
| Main results expected | August 2027 |
| Study ends | December 2027 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07686354 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with either chronic pain (moderate to severe lasting at least 3 months) or generalized anxiety disorder meeting specified screening thresholds.
✕Probably not a fit
Patients with contraindications to MRI/CT, active CNS disorders, or other exclusion criteria may not benefit and could experience no improvement.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm, open-label case study with two cohorts (chronic pain and generalized anxiety disorder) and a 6-month follow-up to explore an accelerated LIFU neuromodulation protocol. The study uses low intensity focused ultrasound as the intervention to see if it can modulate symptoms. Participants must have moderate to severe pain for at least 3 months or meet validated criteria for GAD. The project is conducted at the Fralin Biomedical Research Institute in Roanoke, VA, led by Virginia Tech, with no stated collaborators. Outcome data will inform feasibility and signal of clinical effect, guiding future research.
Why it matters
Potential benefit: If successful, participants may experience reduced pain or anxiety symptoms and improved quality of life.
How similar studies have gone: Prior studies in related neuromodulation approaches have shown promise, but this accelerated LIFU protocol is exploratory and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * GAD Symptoms - GAD-7 score \>= 10, OASIS score \>= 8, or PSWQ score \>= 45. OR Chronic pain symptoms - moderate to severe pain, present for at least 3 months. Exclusion Criteria: * Claustrophobia * Contraindications to MRI or CT * Active medical disorder with CNS effects * History of neurologic disorder * History of head injury with LOC \> 10 minutes * Active drug or alcohol dependence
Where it's running
-
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States Recruiting
Study contacts
- Study coordinator: Jessica Research Associate, MPH
- Email: jnw@vtc.vt.edu
- Phone: 540-526-2261
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.